Literature DB >> 24445228

Sudden cardiac death risk stratification in patients with nonischemic dilated cardiomyopathy.

Jeffrey J Goldberger1, Haris Subačius2, Taral Patel2, Ryan Cunnane3, Alan H Kadish4.   

Abstract

OBJECTIVES: The purpose of this study was to provide a meta-analysis to estimate the performance of 12 commonly reported risk stratification tests as predictors of arrhythmic events in patients with nonischemic dilated cardiomyopathy.
BACKGROUND: Multiple techniques have been assessed as predictors of death due to ventricular tachyarrhythmias/sudden death in patients with nonischemic dilated cardiomyopathy.
METHODS: Forty-five studies enrolling 6,088 patients evaluating the association between arrhythmic events and predictive tests (baroreflex sensitivity, heart rate turbulence, heart rate variability, left ventricular end-diastolic dimension, left ventricular ejection fraction, electrophysiology study, nonsustained ventricular tachycardia, left bundle branch block, signal-averaged electrocardiogram, fragmented QRS, QRS-T angle, and T-wave alternans) were included. Raw event rates were extracted, and meta-analysis was performed using mixed effects methodology. We also used the trim-and-fill method to estimate the influence of missing studies on the results.
RESULTS: Patients were 52.8 ± 14.5 years of age, and 77% were male. Left ventricular ejection fraction was 30.6 ± 11.4%. Test sensitivities ranged from 28.8% to 91.0%, specificities from 36.2% to 87.1%, and odds ratios from 1.5 to 6.7. Odds ratio was highest for fragmented QRS and TWA (odds ratios: 6.73 and 4.66, 95% confidence intervals: 3.85 to 11.76 and 2.55 to 8.53, respectively) and lowest for QRS duration (odds ratio: 1.51, 95% confidence interval: 1.13 to 2.01). None of the autonomic tests (heart rate variability, heart rate turbulence, baroreflex sensitivity) were significant predictors of arrhythmic outcomes. Accounting for publication bias reduced the odds ratios for the various predictors but did not eliminate the predictive association.
CONCLUSIONS: Techniques incorporating functional parameters, depolarization abnormalities, repolarization abnormalities, and arrhythmic markers provide only modest risk stratification for sudden cardiac death in patients with nonischemic dilated cardiomyopathy. It is likely that combinations of tests will be required to optimize risk stratification in this population.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  arrhythmia; cardiomyopathy; sudden death

Mesh:

Year:  2014        PMID: 24445228     DOI: 10.1016/j.jacc.2013.12.021

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  51 in total

Review 1.  Sudden Cardiac Death Substrate Imaged by Magnetic Resonance Imaging: From Investigational Tool to Clinical Applications.

Authors:  Katherine C Wu
Journal:  Circ Cardiovasc Imaging       Date:  2017-07       Impact factor: 7.792

2.  T wave positivity in lead aVR is associated with mortality in patients with cardiac resynchronization therapy.

Authors:  Yahya Kemal İçen; Yurdaer Dönmez; Hasan Koca; Mehmet Uğurlu; Mevlüt Koç
Journal:  J Interv Card Electrophysiol       Date:  2018-04-08       Impact factor: 1.900

Review 3.  The spectrum of epidemiology underlying sudden cardiac death.

Authors:  Meiso Hayashi; Wataru Shimizu; Christine M Albert
Journal:  Circ Res       Date:  2015-06-05       Impact factor: 17.367

Review 4.  Sudden cardiac death risk stratification.

Authors:  Marc W Deyell; Andrew D Krahn; Jeffrey J Goldberger
Journal:  Circ Res       Date:  2015-06-05       Impact factor: 17.367

Review 5.  [ICD therapy in the primary prevention of sudden cardiac death: Risk stratification and patient selection].

Authors:  J Neuzner; R Gradaus
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-06-04

Review 6.  Arrhythmic risk stratification in heart failure: Time for the next step?

Authors:  Konstantinos A Gatzoulis; Antonios Sideris; Emmanuel Kanoupakis; Skevos Sideris; Nikolaos Nikolaou; Christos-Konstantinos Antoniou; Theofilos M Kolettis
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-02-03       Impact factor: 1.468

7.  Impact of T wave amplitude in lead aVR on predicting cardiac events in ischemic and nonischemic cardiomyopathy patients with an implantable cardioverter defibrillator.

Authors:  Yoshihiro Tanaka; Tetsuo Konno; Yudai Tamura; Toyonobu Tsuda; Hiroshi Furusho; Masayuki Takamura; Kenji Sakata; Masakazu Yamagishi; Kenshi Hayashi
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-04-25       Impact factor: 1.468

Review 8.  Clinical neurocardiology defining the value of neuroscience-based cardiovascular therapeutics.

Authors:  Kalyanam Shivkumar; Olujimi A Ajijola; Inder Anand; J Andrew Armour; Peng-Sheng Chen; Murray Esler; Gaetano M De Ferrari; Michael C Fishbein; Jeffrey J Goldberger; Ronald M Harper; Michael J Joyner; Sahib S Khalsa; Rajesh Kumar; Richard Lane; Aman Mahajan; Sunny Po; Peter J Schwartz; Virend K Somers; Miguel Valderrabano; Marmar Vaseghi; Douglas P Zipes
Journal:  J Physiol       Date:  2016-06-14       Impact factor: 5.182

Review 9.  New approaches to predicting the risk of sudden death.

Authors:  Elijah Behr; Bode Ensam
Journal:  Clin Med (Lond)       Date:  2016-06       Impact factor: 2.659

10.  Predictors of serious arrhythmic events in patients with nonischemic heart failure.

Authors:  Mauricio Pimentel; André Zimerman; Diego Chemello; Vanessa Giaretta; Michael Andrades; Daiane Silvello; Leandro Zimerman; Luis E Rohde
Journal:  J Interv Card Electrophysiol       Date:  2016-12-10       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.